Old Second National Bank of Aurora’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
19,247
-296
-2% -$63.7K 0.91% 30
2026
Q1
$4.25M Buy
19,543
+8
+0% +$1.77K 0.88% 32
2025
Q4
$4.46M Sell
19,535
-1
-0% -$228 0.89% 32
2025
Q3
$4.52M Sell
19,536
-730
-4% -$149K 0.93% 31
2025
Q2
$3.76M Sell
20,266
-818
-4% -$152K 0.82% 34
2025
Q1
$4.42M Sell
21,084
-1,274
-6% -$248K 1.04% 25
2024
Q4
$3.97M Buy
22,358
+74
+0.3% +$13.6K 0.9% 30
2024
Q3
$4.4M Sell
22,284
-661
-3% -$123K 1.06% 26
2024
Q2
$3.94M Sell
22,945
-1,099
-5% -$182K 1.01% 27
2024
Q1
$4.38M Sell
24,044
-1,289
-5% -$222K 1.14% 26
2023
Q4
$3.93M Sell
25,333
-392
-2% -$57.1K 1.08% 26
2023
Q3
$3.83M Sell
25,725
-733
-3% -$108K 1.17% 23
2023
Q2
$3.56M Sell
26,458
-407
-2% -$59.7K 1.03% 27
2023
Q1
$4.28M Sell
26,865
-909
-3% -$139K 1.25% 21
2022
Q4
$4.49M Sell
27,774
-1,172
-4% -$180K 1.33% 20
2022
Q3
$3.88M Sell
28,946
-1,547
-5% -$222K 1.19% 22
2022
Q2
$4.67M Sell
30,493
-1,548
-5% -$237K 1.3% 20
2022
Q1
$5.19M Sell
32,041
-1,399
-4% -$203K 1.3% 19
2021
Q4
$3.43M Buy
33,440
+103
+0.3% +$12.2K 1.02% 30
2021
Q3
$3.6M Buy
33,337
+274
+0.8% +$31.3K 0.97% 33
2021
Q2
$3.73M Sell
33,063
-962
-3% -$108K 1.02% 31
2021
Q1
$3.68M Buy
34,025
+467
+1% +$50K 1.03% 34
2020
Q4
$3.6M Sell
33,558
-125
-0.4% -$12K 1.07% 30
2020
Q3
$2.95M Sell
33,683
-1,462
-4% -$138K 0.97% 35
2020
Q2
$3.45M Sell
35,145
-2,326
-6% -$205K 1.17% 27
2020
Q1
$2.85M Buy
37,471
+7,691
+26% +$655K 1.13% 27
2019
Q4
$2.64M Buy
29,780
+623
+2% +$51.7K 0.79% 48
2019
Q3
$2.21M Sell
29,157
-858
-3% -$58.8K 0.74% 57
2019
Q2
$2.18M Sell
30,015
-94
-0.3% -$7.39K 0.77% 56
2019
Q1
$2.43M Buy
30,109
+5,999
+25% +$491K 0.87% 48
2018
Q4
$2.22M Buy
24,110
+916
+4% +$80.6K 0.9% 46
2018
Q3
$2.19M Buy
23,194
+935
+4% +$88.7K 0.8% 56
2018
Q2
$2.06M Buy
22,259
+8,103
+57% +$791K 0.81% 50
2018
Q1
$1.34M Sell
14,156
-642
-4% -$70.5K 0.54% 66
2017
Q4
$1.43M Sell
14,798
-320
-2% -$30.2K 0.57% 64
2017
Q3
$1.34M Buy
15,118
+883
+6% +$67.2K 0.56% 67
2017
Q2
$1.03M Sell
14,235
-220
-2% -$14.8K 0.44% 71
2017
Q1
$942K Sell
14,455
-159
-1% -$10K 0.42% 73
2016
Q4
$915K Sell
14,614
-780
-5% -$47.6K 0.41% 72
2016
Q3
$971K Sell
15,394
-2,225
-13% -$144K 0.45% 71
2016
Q2
$1.09M Sell
17,619
-1,111
-6% -$67.7K 0.51% 71
2016
Q1
$1.07M Sell
18,730
-2,000
-10% -$111K 0.51% 65
2015
Q4
$1.23M Buy
20,730
+111
+0.5% +$6.39K 0.6% 60
2015
Q3
$1.12M Sell
20,619
-468
-2% -$30.5K 0.56% 65
2015
Q2
$1.42M Sell
21,087
-100
-0.5% -$6.53K 0.64% 63
2015
Q1
$1.24M Hold
21,187
0.55% 66
2014
Q4
$1.39M Hold
21,187
0.61% 60
2014
Q3
$1.22M Sell
21,187
-330
-2% -$18.3K 0.6% 57
2014
Q2
$1.21M Sell
21,517
-1,700
-7% -$89.2K 0.6% 57
2014
Q1
$1.19M Hold
23,217
0.6% 53
2013
Q4
$1.23M Sell
23,217
-610
-3% -$30K 0.51% 55
2013
Q3
$1.06M Sell
23,827
-1,418
-6% -$62.9K 0.48% 56
2013
Q2
$1.04M Buy
+25,245
New +$1.1M 0.48% 57

Other funds holding ABBV

Old Second National Bank of Aurora's ABBV Position: Q2 2026 in Review

Old Second National Bank of Aurora reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $63.7K and leaving 19,247 shares worth $4.84M. The position accounts for 0.91% of the portfolio, ranked #30.

Old Second National Bank of Aurora first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.19M in Q1 2022. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Old Second National Bank of Aurora held 19,247 shares of AbbVie worth $4.84M as of Q2 2026.
  • Old Second National Bank of Aurora sold 296 AbbVie shares in Q2 2026, an estimated $63.7K.
  • AbbVie made up 0.91% of Old Second National Bank of Aurora's portfolio in Q2 2026, its #30 holding.
  • Old Second National Bank of Aurora first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Old Second National Bank of Aurora's AbbVie position peaked at $5.19M in Q1 2022.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Old Second National Bank of Aurora's 13F filing for Q2 2026, filed 21 Jul 2026.